LEXINGTON, Mass.--(BUSINESS WIRE)--Predictive Biosciences today announced that the Company will be presenting an update on its non-invasive diagnostic assays for bladder cancer detection during the GTCbio’s Oncology Biomarkers Conference, being held January 27 – 28 in San Diego, CA. The conference focuses on topics paramount to the continuing progress of biomarker research and development.
